Article Details

Vancouver biotech NervGen raises $23M in bought deal

Retrieved on: 2024-04-01 23:20:48

Tags for this article:

Click the tags to see associated articles and topics

Vancouver biotech NervGen raises $23M in bought deal. View article details on hiswai:

Excerpt

Technology. Vancouver biotech NervGen raises $23M in bought deal. Bought deal raise of $23 million to fund ongoing trials of nerve regenerating drug.

Article found on: www.biv.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo